Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Oncol.

Sec. Hematologic Malignancies

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1711784

Correction: TARGETING RAB7 IN HUMAN B LYMPHOMA BY A SMALL MOLECULE INHIBITOR ARRESTS TUMOR CELL GROWTH

Provisionally accepted
Maria FernandezMaria Fernandez1Rui WangRui Wang1Jingwei WangJingwei Wang1Shuai WuShuai Wu1Kenneth HolderKenneth Holder2Alia NazarullahAlia Nazarullah2Ricardo AguiarRicardo Aguiar3Zijun Y. Xu-MonetteZijun Y. Xu-Monette4Ken YoungKen Young4Hui YanHui Yan1*Zhenming XuZhenming Xu1
  • 1Department of Microbiology, Immunology and Molecular Genetics, Joe R. & Teresa Lozano Long School of Medicine, The University of Texas at San Antonio, San Antonio, United States
  • 2Department of Pathology, Joe R. & Teresa Lozano Long School of Medicine, The University of Texas at San Antonio, San Antonio, United States
  • 3Department of Medicine, University of Texas Long School of Medicine, South Texas Veterans Health Care System, Audie Murphy VA Hospital, San Antonio, United States
  • 4Hematopathology Division and Department of Pathology, Duke University Medical Center, Duke Cancer Institute, Durham, United States

This article is a correction to:

  1. Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth

    1. Read original article

The final, formatted version of the article will be published soon.

Select one of your emails

You have multiple emails registered with Frontiers:

Notify me on publication

Please enter your email address:

If you already have an account, please login

You don't have a Frontiers account ? You can register here

Keywords: B cell lymphoma, Burkitt Lymphoma, CID1067700, Diffuse large B-cell lymphoma, FX1, MβCD, NF-kB, Rab7

Received: 23 Sep 2025; Accepted: 24 Sep 2025.

Copyright: © 2025 Fernandez, Wang, Wang, Wu, Holder, Nazarullah, Aguiar, Xu-Monette, Young, Yan and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Hui Yan, yanh3@uthscsa.edu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Supplementary Material